Vital Signs
-
13 Aug 2012  |  North America
Vital Signs - Recent Advancements in Drug Delivery Novel Formulations and Technologies Offer Improved Treatment Options
This issue of Vital Signs, released on August 13, 2012, provides an insight in to the recent advancements in drug delivery. Additionally, a company spotlight is provided for Ratio. Ratio, Inc. is a start-up company focused on the development of a novel hydrogel-powered injectable drug delivery device that is worn like a patch. Reimbursement a...
$1,500.00 -
20 Jul 2012  |  North America
Vital Signs - Healthcare News - The Analyst's Perspective - July Issue
This issue of Vital Signs, released on July 20, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.
$1,500.00 -
13 Jul 2012  |  North America
Vital Signs - Getting Down to the Business of Green Medical Imaging
This issue of Vital Signs, released on July 13, 2012, provides an insight in to the green medical imaging market. Additionally, a company spotlight is provided for Karos Health. Building on 20 years of experience in the diagnostic imaging industry, Karos Health has a particular focus on creating secure and seamless imaging exchange networks. K...
$1,500.00 -
27 Jun 2012  |  North America
Vital Signs - Healthcare News - The Analyst's Perspective - June Issue
This issue of Vital Signs, released on June 27, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.
$1,500.00 -
26 Jun 2012  |  North America
Vital Signs - Special Edition - Perspectives on Wellness from the Digital Health Summer Summit
This issue of Vital Signs, released on June 26, 2012, provides commentary on the Digital Health Summer Summit by Healthcare Research Director, Daniel Ruppar. This event took place on June 14-15 2012 in San Diego, California. Frost & Sullivan was a Strategic Partner with the event; participation included speaking engagement by Senior Industry Analy...
$1,500.00 -
20 Jun 2012  |  North America
Vital Signs - Global Biosimilars Market: Patent Expiries of Blockbuster Biologics Provide Large Market Opportunity
This issue of Vital Signs, released on June 20, 2012, provides an insight in to the global biosimilars market. Additionally, a company spotlight is provided for Dragonfly Sciences. Dragonfly Sciences is a private biotechnology company specializing in the development of biosimilar monoclonal antibodies and soluble receptors. Reimbursement and r...
$1,500.00 -
21 May 2012  |  North America
Vital Signs - Healthcare News - The Analyst's Perspective - May Issue
This issue of Vital Signs, released on May 21, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.
$1,500.00 -
07 May 2012  |  North America
Vital Signs - Cutting the Fat: Taking a Look at Wasteful Healthcare Spending
This issue of Vital Signs, released on May 7, 2012, provides an insight in to healthcare spending in the U.S. Additionally, a company spotlight is provided for Apollo Endosurgery, Inc.Apollo Endosurgery is a privately held company based out of Austin, Texas. It is focused on the development of novel minimally and less-invasive surgical tools. R...
$1,500.00 -
02 May 2012  |  North America
Vital Signs - Medical Image Sharing and Management Drives Collaborative Care
This issue of Vital Signs, released on May 2, 2012, provides a strategic insight on use of IT solutions for medical image sharing and management. Additionally, a company spotlight is provided for Laurel Bridge Software. Engineers from Laurel Bridge Software, Inc. and Blair Computing Systems, Inc. have been developing technical software since 19...
$1,500.00 -
23 Apr 2012  |  North America
Vital Signs - Healthcare News - The Analyst's Perspective - April Issue
This issue of Vital Signs, released on April 23, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.
$1,500.00